Santen Pharmaceutical Co., Ltd. - stock earnings

SNPHF Quarterly earnings

DateEarningsRevenue
2023Q4 52.0 million USD 546.2 million USD
2023Q3 59.4 million USD 491.5 million USD
2023Q2 72.0 million USD 500.8 million USD
2023Q1 8.4 million USD 596.7 million USD
2022Q4 45.6 million USD 541.2 million USD
2022Q3 -198.7 million USD 438.7 million USD
2022Q2 48.9 million USD 480.6 million USD
2022Q1 64.8 million USD 576.5 million USD
2021Q4 43.8 million USD 582.6 million USD
2021Q3 62.2 million USD 572.9 million USD
2021Q2 66.4 million USD 584.9 million USD
2021Q1 -127.4 million USD 612.2 million USD
2020Q4 70.2 million USD 609.1 million USD
2020Q3 71.9 million USD 581.9 million USD
2020Q2 57.3 million USD 533.2 million USD
2020Q1 30.9 million USD 548.3 million USD
2019Q4 65.6 million USD 583.6 million USD
2019Q3 62.7 million USD 555.0 million USD
2019Q2 59.3 million USD 548.9 million USD
2019Q1 77.5 million USD 549.8 million USD
2018Q4 81.5 million USD 533.4 million USD
2018Q3 66.4 million USD 510.4 million USD
2018Q2 62.0 million USD 511.2 million USD
2018Q1 74.3 million USD 529.3 million USD
2017Q4 107.2 million USD 512.3 million USD
2017Q3 55.4 million USD 487.5 million USD
2017Q2 79.6 million USD 499.6 million USD
2017Q1 29.0 million USD 433.3 million USD
2016Q4 61.7 million USD 451.8 million USD
2016Q3 52.2 million USD 472.6 million USD
2016Q2 71.3 million USD 486.7 million USD
2016Q1 31.0 million USD 410.2 million USD
2015Q4 51.7 million USD 426.2 million USD
2015Q3 301.3 million USD 416.3 million USD
2015Q2 61.5 million USD 391.4 million USD
2015Q1 65.4 million USD 374.9 million USD
2014Q4 59.4 million USD 376.0 million USD
2014Q3 49.1 million USD 349.6 million USD
2014Q2 36.8 million USD 332.1 million USD
2014Q1 16.8 million USD 386.0 million USD
2013Q4 60.8 million USD 378.2 million USD
2013Q3 35.1 million USD 357.3 million USD
2013Q2 56.5 million USD 348.5 million USD
2013Q1 25.3 million USD 325.3 million USD
2012Q4 59.6 million USD 366.7 million USD
2012Q3 60.6 million USD 370.5 million USD
2012Q2 53.9 million USD 352.5 million USD
2012Q1 29.1 million USD 340.1 million USD
2011Q4 62.6 million USD 381.9 million USD
2011Q3 57.1 million USD 377.1 million USD
2011Q2 68.5 million USD 345.0 million USD
2011Q1 80.1 million USD 345.3 million USD
2010Q4 66.3 million USD 346.0 million USD
2010Q3 56.0 million USD 330.7 million USD
2010Q2 51.8 million USD 296.5 million USD
2010Q1 26.5 million USD 259.7 million USD
2009Q4 49.2 million USD 292.4 million USD
2009Q3 57.0 million USD 331.8 million USD
2009Q2 68.0 million USD 304.2 million USD
2009Q1 24.4 million USD 240.5 million USD
2008Q4 43.9 million USD 282.0 million USD
2008Q3 33.8 million USD 252.2 million USD

SNPHF Yearly earnings

DateEarningsRevenue
2023 -112.5 million USD 2.1 billion USD
2022 222.7 million USD 2.2 billion USD
2021 61.7 million USD 2.3 billion USD
2020 218.6 million USD 2.2 billion USD
2019 288.8 million USD 2.1 billion USD
2018 331.2 million USD 2.1 billion USD
2017 206.3 million USD 1.8 billion USD
2016 475.0 million USD 1.7 billion USD
2015 200.3 million USD 1.3 billion USD
2014 166.3 million USD 1.4 billion USD
2013 175.4 million USD 1.3 billion USD
2012 208.6 million USD 1.4 billion USD
2011 256.6 million USD 1.3 billion USD
2010 200.2 million USD 1.2 billion USD
2009 102.3 million USD 1.0 billion USD
2008 126.7 million USD 1.0 billion USD
2007 111.6 million USD 853.1 million USD
2006 110.6 million USD 835.7 million USD
2005 102.9 million USD 865.3 million USD

SNPHF

Price: $9.45

52 week price:
7.17
10.60

Dividend Yield: 2.49%

5-year range yield:
1.98%
259.65%

Forward Dividend Yield: 5.08%

Payout Ratio: 101.28%

Payout Ratio Range:
0.34%
101.28%

Dividend Per Share: 0.48 USD

Earnings Per Share: 0.47 USD

P/E Ratio: 21.15

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 3.5 billion

Average Dividend Frequency: 2

Years Paying Dividends: 20

DGR3: -2.03%

DGR5: 30.00%

DGR10: 30.00%

Links: